$16.7 B

ABMD Mkt cap, 15-Oct-2018

$180 M

ABIOMED Revenue Q1, 2019
ABIOMED Gross profit (Q1, 2019)149.2 M
ABIOMED Gross profit margin (Q1, 2019), %82.9%
ABIOMED Net income (Q1, 2019)90.1 M
ABIOMED EBIT (Q1, 2019)46.7 M
ABIOMED Cash, 30-Jun-201861.3 M

ABIOMED Income Statement

Annual

USDFY, 2014FY, 2015Y, 2016FY, 2017FY, 2018

Revenue

183.6m230.3m329.5m445.3m593.7m

Revenue growth, %

25%43%35%

Cost of goods sold

98.6m

Gross profit

495.2m

Gross profit Margin, %

83%

R&D expense

66.4m75.3m

General and administrative expense

218.2m262.7m

Operating expense total

284.5m436.6m

EBIT

8.4m28.7m65.1m90.1m157.1m

EBIT margin, %

5%12%20%20%26%

Pre tax profit

8.5m28.8m65.8m91.3m160.4m

Income tax expense

1.2m(84.9m)27.7m39.2m48.3m

Net Income

7.4m113.7m38.1m52.1m112.2m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2019

Revenue

44.3m46.2m48.8m51.9m62.0m73.4m76.4m85.8m103.0m103.0m114.7m132.5m132.8m180.0m

Cost of goods sold

30.9m

Gross profit

149.2m

Gross profit Margin, %

83%

R&D expense

7.7m7.8m9.1m8.7m8.4m10.2m11.6m13.8m15.7m18.1m16.3m16.9m19.4m21.3m

General and administrative expense

26.2m24.4m31.6m29.5m30.1m37.3m39.8m41.9m51.0m53.1m53.9m60.6m60.1m81.1m

Operating expense total

42.9m41.6m50.3m47.8m48.3m58.4m63.5m68.4m81.8m88.4m89.3m99.4m101.1m133.3m

EBIT

1.4m4.6m(1.5m)4.2m13.7m15.0m12.8m17.4m21.2m14.5m25.4m33.1m31.7m46.7m

EBIT margin, %

3%10%(3%)8%22%20%17%20%21%14%22%25%24%26%

Pre tax profit

1.4m4.7m4.2m13.7m15.1m13.0m17.5m21.4m14.7m25.8m33.8m32.5m48.5m

Income tax expense

370.0k258.0k226.0k336.0k1.0m6.3m5.2m6.9m8.5m5.9m10.4m(3.6m)8.0m(41.6m)

Net Income

1.1m4.4m(1.7m)3.8m12.7m8.9m7.7m10.6m12.9m8.9m15.4m37.4m24.5m90.1m

ABIOMED Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

20.9m22.4m48.2m39.0m43.0m

Accounts Receivable

24.4m31.8m42.8m54.1m70.0m

Inventories

13.9m16.8m26.7m34.9m50.2m

Current Assets

118.0m220.1m288.4m327.0m494.3m

PP&E

6.9m9.1m23.2m87.8m117.2m

Goodwill

38.0m31.5m33.0m31.0m35.8m

Total Assets

205.4m338.4m423.9m550.4m786.4m

Accounts Payable

7.7m10.4m9.4m20.6m23.6m

Short-term debt

Current Liabilities

30.4m39.3m46.5m69.6m84.7m

Long-term debt

Total Liabilities

98.3m96.9m

Additional Paid-in Capital

436.1m465.0m508.6m566.0m619.9m

Retained Earnings

(250.9m)(137.2m)(99.1m)(47.0m)140.5m

Total Equity

168.4m291.6m368.8m452.1m689.5m

Financial Leverage

1.2 x1.2 x1.1 x1.2 x1.1 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2019

Cash

10.1m22.6m34.7m17.5m19.5m40.4m54.4m53.2m38.3m54.7m61.1m44.0m44.5m61.3m

Accounts Receivable

21.1m23.0m22.8m23.1m28.4m34.4m37.1m36.8m41.3m46.6m50.2m53.6m57.3m67.5m

Inventories

15.6m14.8m13.9m13.4m15.4m21.2m23.0m25.5m29.1m31.5m32.1m36.9m40.6m55.8m

Current Assets

110.6m119.7m127.2m135.3m160.6m244.1m265.4m281.7m300.3m319.9m333.4m350.9m370.2m497.3m

PP&E

6.4m7.0m6.7m7.4m7.6m10.2m11.4m15.0m26.0m50.2m60.9m92.8m97.7m127.3m

Goodwill

37.3m38.0m37.7m36.9m35.3m32.2m32.7m31.7m32.3m32.6m30.6m33.2m34.3m33.9m

Total Assets

181.0m193.4m206.2m215.5m240.8m352.0m373.4m391.6m429.3m474.9m501.0m652.2m694.7m812.0m

Accounts Payable

6.2m6.1m6.8m7.6m8.2m8.6m8.8m8.8m8.4m14.1m14.6m12.8m16.7m25.7m

Current Liabilities

24.0m26.4m29.0m27.1m31.4m36.3m34.5m37.7m43.2m51.9m58.9m59.0m63.4m76.7m

Total Liabilities

30.3m32.9m35.8m40.0m45.1m44.0m42.3m46.1m52.0m76.5m83.6m85.2m89.8m88.7m

Additional Paid-in Capital

427.2m431.8m441.3m447.4m457.9m474.5m489.5m496.0m520.8m536.9m546.8m580.0m592.1m638.0m

Retained Earnings

(258.9m)(254.5m)(252.6m)(248.8m)(236.1m)(128.4m)(120.6m)(110.1m)(86.2m)(77.3m)(61.9m)65.7m90.2m230.5m

Total Equity

150.7m160.5m170.4m175.5m195.7m308.1m331.1m345.5m377.3m398.4m417.4m567.0m604.9m723.4m

Financial Leverage

1.2 x1.2 x1.2 x1.2 x1.2 x1.1 x1.1 x1.1 x1.1 x1.2 x1.2 x1.2 x1.1 x1.1 x

ABIOMED Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

7.4m113.7m38.1m52.1m112.2m

Depreciation and Amortization

2.8m3.3m6.2m11.0m

Accounts Receivable

(1.3m)(8.0m)(11.0m)(11.5m)(15.3m)

Inventories

(622.0k)(7.0m)(11.0m)(12.3m)(15.7m)

Accounts Payable

(54.0k)3.4m(2.6m)7.6m4.4m

Cash From Operating Activities

23.5m43.3m76.8m115.1m192.5m

Purchases of PP&E

(2.8m)(5.2m)(15.6m)(50.4m)(55.9m)

Cash From Investing Activities

(22.3m)(49.9m)(57.7m)(126.3m)(180.8m)

Cash From Financing Activities

9.6m9.5m7.2m3.9m(9.1m)

Income Taxes Paid

1.3m1.2m848.0k1.4m4.6m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2019

Net Income

(664.0k)3.7m(1.7m)3.8m12.7m8.9m7.7m10.6m12.9m8.9m15.4m90.1m

Depreciation and Amortization

1.3m1.9m3.0m

Accounts Receivable

1.9m123.0k22.8m23.1m28.4m34.4m37.1m36.8m41.3m46.6m50.2m1.9m

Inventories

(876.0k)(69.0k)13.9m13.4m15.4m21.2m23.0m25.5m29.1m31.5m32.1m(7.8m)

Accounts Payable

(1.5m)(1.7m)6.8m7.6m8.2m8.6m8.8m8.8m8.4m14.1m14.6m2.7m

Cash From Operating Activities

5.1m13.6m46.6m

Purchases of PP&E

(1.2m)(2.3m)(15.1m)

Cash From Investing Activities

(10.1m)(9.1m)34.8m

Cash From Financing Activities

5.2m8.1m(61.8m)

Income Taxes Paid

1.1m3.0m

ABIOMED Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information